What is the difference between Gonadorelin and Kisspeptin-54?

Gonadorelin: Synthetic GnRH that binds pituitary GnRH receptors; pulsatile dosing stimulates LH/FSH release; used to maintain HPG axis during TRT Kisspeptin-54: Full-length kisspeptin (54 amino acids); binds KISS1R on GnRH neurons with higher receptor occupancy and longer duration than KP-10; induces more sustained GnRH/LH pulses

Is Gonadorelin FDA approved?

Gonadorelin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Kisspeptin-54 FDA approved?

Kisspeptin-54 is investigational and not FDA approved. It is discussed for research and educational purposes only, not as medical guidance.

How is Gonadorelin administered in research settings?

In research settings, Gonadorelin is typically administered via the subcutaneous or intravenous routes. PeptideBase does not provide dosing or administration instructions.

How is Kisspeptin-54 administered in research settings?

In research settings, Kisspeptin-54 is typically administered via the subcutaneous or intravenous routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Gonadorelin vs Kisspeptin-54

Peptide Comparison

Gonadorelin vs Kisspeptin-54

Both are Reproductive & Hormonal peptides.

Gonadorelin

GnRH

Sexual HealthNot EvaluatedCompoundable

Half-life: ~2-4 minutes

25 providers listed

Full Gonadorelin profile →

Kisspeptin-54

KP-54

Sexual HealthInvestigationalResearch Only

Half-life: ~29 minutes

12 providers listed

Full Kisspeptin-54 profile →

Bottom line

Kisspeptin-54 has a longer half-life than Gonadorelin, so it generally needs less frequent dosing.

Quick Verdict

Gonadorelin

Evidence

Established Clinical

Half-life

~2-4 minutes

Kisspeptin-54

Evidence

Established Clinical

Half-life

~29 minutes

Which One Should You Choose?

Your goal	Better option
Further along in FDA review	Kisspeptin-54
Less frequent dosing (longer half-life)	Kisspeptin-54
More provider options (25 vs 12)	Gonadorelin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Gonadorelin

Kisspeptin-54

Mechanism Family

Reproductive & Hormonal

Half-life

~2-4 minutes

~29 minutes

FDA Status

not evaluated

investigational

Admin Routes

subcutaneous, intravenous

Availability

Compoundable

Research Only

Providers

25 listed

12 listed

Avail. Notes

Previously FDA-approved as Factrel (NDA 017019). Voluntarily discontinued by manufacturer. Included on the FDA 503B outsourcing-facility bulk-substances list (Category 1), not the 503A pharmacy list. Prescription compounded product.

No FDA approval. Longer-acting kisspeptin isoform under Phase 1/2 investigation for reproductive disorders in EU and US. No NDA filed. Research peptide only.

Research Evidence

Gonadorelin

Established ClinicalMeta-analysis · 5 key studies · most recent 2026

Kisspeptin-54

Established ClinicalRCT · 8 key studies · most recent 2025

Research Citations

Gonadorelin

Cohort2026 · J Reprod Dev

Effect of post-insemination GnRH analogue administration on pregnancy rates in repeat-breeder cows: compariso…

Cohort2026 · J Dairy Sci

Increasing gonadorelin hydrochloride dose at the first GnRH of breeding Ovsynch enhances luteinizing hormone…

Cohort2025 · Translational Andrology and Urology

Therapeutic effects of a pulsatile GnRH pump on adult male patients with congenital hypogonadotropic hypogona…

Meta-analysis2018 · Fertility and Sterility

Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and fu…

+1 more

Kisspeptin-54

Review2025 · Trends in Endocrinology and Metabolism

Can kisspeptin be a new treatment for sexual dysfunction?

Cohort2025 · Journal of Endocrinological Investigation

Phase-dependent changes in serum kisspeptin and irisin levels across the menstrual cycle in healthy women

RCT2022 · JAMA Netw Open

Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical T…

Cohort2020 · Endocrine

Kisspeptin and LH pulsatility in patients with functional hypothalamic amenorrhea

+4 more

About Gonadorelin

Synthetic GnRH that binds pituitary GnRH receptors; pulsatile dosing stimulates LH/FSH release; used to maintain HPG axis during TRT

Research Areas

pulsatile LH and FSH stimulation from the pituitarytesticular function and testosterone production maintenancefertility preservation alongside TRT (FSH pathway intact)hypothalamic-pituitary axis restoration in hypogonadism

About Kisspeptin-54

Full-length kisspeptin (54 amino acids); binds KISS1R on GnRH neurons with higher receptor occupancy and longer duration than KP-10; induces more sustained GnRH/LH pulses

Research Areas

sustained LH/FSH stimulationtestosterone supportfertility inductionreproductive function

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Gonadorelin

Reported (Unverified — Pending Clinical Review)

continuous high-dose (causes receptor downregulation)

No established clinical contraindications

Suggested Monitoring

Total testosteroneLHFSHEstradiol (E2)SHBGProlactin

Standard reproductive endocrinology panels establish HPG axis baseline. LH and FSH confirm pituitary response to gonadorelin; testosterone, E2, and SHBG reflect downstream gonadal output.

Kisspeptin-54

Reported (Unverified — Pending Clinical Review)

hormone-sensitive cancerspregnancy (during treatment)

No established clinical contraindications

Find Providers

Where to source these peptides

Providers offering

Gonadorelin

25 listed

Browse directory →

Providers offering

Kisspeptin-54

12 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Reproductive & Hormonal Comparisons

Browse all peptides →

Educational research tools — not medical advice.